USD10
ORIC Shares
About ORIC PharmaceuticalsORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
USD10
ORIC Shares
About ORIC PharmaceuticalsORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Stats
TRADING WINDOW
Closed
OPENS AT
Mar 27 at 1:30 PM GMT+0
MARKET CAP
$1.17B
OPEN PRICE
$12.13
LOW (1Y)
$3.90
HIGH (1Y)
$14.93
LOW (24H)
$11.76
HIGH (24H)
$12.74
VOLUME (24H)
$1.35M
22.8%
Price history
Time | Price | Change |
|---|---|---|
Today | $12.13 | |
1 Day | $12.30 | |
1 Week | $11.16 | |
1 Month | $13.39 | |
1 Year | $6.14 |